Alan G. Wasserman - Concepedia

Author

Alan G. Wasserman

Also Known As

A G Wasserman, A Wasserman, A. WASSERMAN, A. Wasserman, Alan G Wasserman, Alan G. Wasserman, Alan Wasserman, Alan G. Wasserman

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

George Washington University Washington University Medical Center Ross School Washington Center Georgetown University

About

Alan G. Wasserman is an author at George Washington University specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	27	2.7K
2	Public Health	10	10	700
3	Health Sciences	3	3	101
4	Applied Physiology	2	2	83
5	Nursing	1	1	36

Alan G. Wasserman

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction Thomas M. Maddox, James L. Januzzi, Larry A. Allen, Journal of the American College of Cardiology Heart FailurePivotal IssuesCardiovascular DiseaseClinical Decision SupportCardiac Care	2021	825
2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction Clyde W. Yancy, James L. Januzzi, Larry A. Allen, Journal of the American College of Cardiology Heart FailurePivotal IssuesCardiovascular DiseaseClinical Decision SupportCardiac Care	2017	279
2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction Thomas M. Maddox, James L. Januzzi, Larry A. Allen, Journal of the American College of Cardiology Critical Care MedicineHeart FailureCardiovascular DiseaseClinical Decision SupportCardiac Care	2024	189
A randomized, angiographically controlled trial of intracoronary streptokinase in acute myocardial infarction Roy H. Leiboff, Richard J. Katz, Alan G. Wasserman, The American Journal of Cardiology ThrombosisCardiogenic ShockIntracoronary StreptokinaseCardiovascular DiseaseMyocardial Infarction	1984	180
Acute arrhythmogenicity of doxorubicin administration Jonathan S. Steinberg, Alice J. Cohen, Alan G. Wasserman, Cancer Heart FailurePharmacotherapyDrug ResistanceInflammationThrombosis	1987	169
One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial. David O. Williams, Eugene Braunwald, Genell L. Knatterud, Circulation	1992	138
Temporal evolution of the human coronary collateral circulation after myocardial infarction Harry Schwartz, Roy H. Leiboff, George B. Bren, Journal of the American College of Cardiology Cardiovascular DiseaseMyocardial InfarctionPhysiologyCardiologyAcute Myocardial Infarction	1984	131
Prevention of nitrate tolerance with angiotension converting enzyme inhibitors. Richard J. Katz, Warren S. Levy, Leslie A. Buff, Circulation	1991	115
Randomized, multicenter, double-blind, placebo-controlled evaluation of amlodipine in patients with mild-to-moderate heart failure Milton Packer, Pascal Nicod, Bijoy R. Khandheria, Journal of the American College of Cardiology Heart FailureCardiovascular DiseaseMedicinePlacebo-controlled EvaluationCardiovascular Pharmacology	1991	104
Association of Serum Antibodies to Heat-Shock Protein 65 With Coronary Calcification Levels Jianhui Zhu, Richard J. Katz, Arshed A. Quyyumi, Circulation	2003	84

Page 1